SH

Shabnam Haseeb

Director Director DIN 03556431
DIN 03556431 First appointment Jun 2011 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2011
Shareholding value Locked Premium profile

About Shabnam Haseeb

Data last updated:

Shabnam Haseeb has 15 years in corporate governance. Formerly with 1 company, such as Manrich Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03556431
Primary Designation Director
First Appointment 28 Jun 2011
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Manrich Pharma Private Limited U85191UP2011PTC045465
Director28 Jun 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Manrich Pharma Private Limited
Premium access

Shareholding and investment profile for Shabnam Haseeb

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shabnam Haseeb

Shabnam Haseeb has 15 years in corporate governance. Formerly with 1 company, such as Manrich Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Shabnam Haseeb is associated with 0 companies as a director.

Shabnam Haseeb has expertise in General Business.

Shabnam Haseeb has 15 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available